M. A. Vlasova

606 total citations
18 papers, 461 citations indexed

About

M. A. Vlasova is a scholar working on Molecular Biology, Physiology and Materials Chemistry. According to data from OpenAlex, M. A. Vlasova has authored 18 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Materials Chemistry. Recurrent topics in M. A. Vlasova's work include Nitric Oxide and Endothelin Effects (3 papers), Advanced Proteomics Techniques and Applications (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). M. A. Vlasova is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Advanced Proteomics Techniques and Applications (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). M. A. Vlasova collaborates with scholars based in Russia, Finland and United Kingdom. M. A. Vlasova's co-authors include Karl‐Heinz Herzig, Kristiina Järvinen, Joakim Riikonen, Jarno Salonen, Vesa‐Pekka Lehto, Sergei A. Moshkovskii, Juha Mönkäre, Anne Huotari, Anna‐Kaisa Purhonen and José M. Pascual and has published in prestigious journals such as Pharmacological Reviews, Journal of Controlled Release and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

M. A. Vlasova

17 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. A. Vlasova Russia 11 129 119 102 69 60 18 461
Chen Wei China 11 180 1.4× 101 0.8× 151 1.5× 60 0.9× 16 0.3× 22 490
Satoko Ueda Japan 14 243 1.9× 143 1.2× 53 0.5× 105 1.5× 21 0.3× 21 790
Wonkyung Cho United States 14 133 1.0× 50 0.4× 56 0.5× 57 0.8× 19 0.3× 45 691
Igor Grinberg Israel 14 165 1.3× 101 0.8× 137 1.3× 152 2.2× 20 0.3× 29 511
Ye Eun Kim South Korea 11 161 1.2× 94 0.8× 126 1.2× 93 1.3× 15 0.3× 33 670
Ana Cláudia Lima Portugal 12 109 0.8× 47 0.4× 119 1.2× 92 1.3× 19 0.3× 22 445
Jay Hu United States 8 186 1.4× 79 0.7× 88 0.9× 83 1.2× 20 0.3× 8 414
Xuekun Jia China 9 273 2.1× 94 0.8× 107 1.0× 37 0.5× 10 0.2× 10 537
Stelios T. Tzannis United States 9 335 2.6× 48 0.4× 86 0.8× 24 0.3× 11 0.2× 9 648

Countries citing papers authored by M. A. Vlasova

Since Specialization
Citations

This map shows the geographic impact of M. A. Vlasova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Vlasova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Vlasova more than expected).

Fields of papers citing papers by M. A. Vlasova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Vlasova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Vlasova. The network helps show where M. A. Vlasova may publish in the future.

Co-authorship network of co-authors of M. A. Vlasova

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Vlasova. A scholar is included among the top collaborators of M. A. Vlasova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Vlasova. M. A. Vlasova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kovalainen, Miia, Juha Mönkäre, Joakim Riikonen, et al.. (2015). Novel Delivery Systems for Improving the Clinical Use of Peptides. Pharmacological Reviews. 67(3). 541–561. 59 indexed citations
2.
Vlasova, M. A., Jussi Rytkönen, Joakim Riikonen, et al.. (2014). Nanocarriers and the delivered drug: Effect interference due to intravenous administration. European Journal of Pharmaceutical Sciences. 63. 96–102. 6 indexed citations
3.
Vlasova, M. A., О. С. Тарасова, Joakim Riikonen, et al.. (2014). Injected nanoparticles: The combination of experimental systems to assess cardiovascular adverse effects. European Journal of Pharmaceutics and Biopharmaceutics. 87(1). 64–72. 16 indexed citations
4.
Vlasova, M. A., et al.. (2012). A new case of Acute Myeloid Leukemia with semi-cryptic t(7;21)(p22;q22). Atlas of Genetics and Cytogenetics in Oncology and Haematology. 1 indexed citations
5.
Mönkäre, Juha, Joakim Riikonen, M. A. Vlasova, et al.. (2010). Mesoporous silicon microparticles as carriers for peptides. Journal of Controlled Release. 148(1). e43–e44. 3 indexed citations
6.
Vlasova, M. A., Anna‐Kaisa Purhonen, Marjo‐Riitta Järvelin, et al.. (2010). Role of adipokines in obesity‐associated hypertension. Acta Physiologica. 200(2). 107–127. 46 indexed citations
7.
Mönkäre, Juha, Risto Hakala, M. A. Vlasova, et al.. (2010). Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly(ε-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivo. Journal of Controlled Release. 146(3). 349–355. 24 indexed citations
8.
Mönkäre, Juha, M. A. Vlasova, Joakim Riikonen, et al.. (2010). Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery. European Journal of Pharmaceutics and Biopharmaceutics. 77(1). 20–25. 47 indexed citations
9.
Vlasova, M. A., Kristiina Järvinen, & Karl‐Heinz Herzig. (2009). Cardiovascular effects of ghrelin antagonist in conscious rats. Regulatory Peptides. 156(1-3). 72–76. 20 indexed citations
10.
Riikonen, Joakim, M. A. Vlasova, Anne Huotari, et al.. (2009). In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles. Journal of Controlled Release. 137(2). 166–170. 100 indexed citations
11.
Baskova, I. P., et al.. (2008). Proteins and peptides of the salivary gland secretion of medicinal leeches Hirudo verbana, H. medicinalis, and H. orientalis. Biochemistry (Moscow). 73(3). 315–320. 51 indexed citations
12.
Коплик, Е. В., et al.. (2008). Mass spectrometric profile of the serum as a marker of experimental psychoemotional stress in rats. Bulletin of Experimental Biology and Medicine. 145(5). 552–555.
13.
Moshkovskii, Sergei A., et al.. (2006). Acute phase serum amyloid A in ovarian cancer as an important component of proteome diagnostic profiling. PROTEOMICS - CLINICAL APPLICATIONS. 1(1). 107–117. 24 indexed citations
14.
Goufman, Eugene, Sergei A. Moshkovskii, Olga V. Tikhonova, et al.. (2006). Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions. Biochemistry (Moscow). 71(4). 354–360. 40 indexed citations
15.
Vlasova, M. A. & Sergei A. Moshkovskii. (2006). Molecular interactions of acute phase serum amyloid A: Possible involvement in carcinogenesis. Biochemistry (Moscow). 71(10). 1051–1059. 18 indexed citations
16.
Vlasova, M. A., et al.. (2003). Effect of Transmural Pressure on Constrictor Reactions of Caudal Artery in Hypotensive and Hypertensive Rats. Bulletin of Experimental Biology and Medicine. 136(1). 30–33. 1 indexed citations
17.
Vlasova, M. A., et al.. (1999). Vasoconstriction reactions in tail artery in the rats with regional arterial hypotension. Bulletin of Experimental Biology and Medicine. 127(1). 7–9. 2 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026